A new overview of systematic reviews consolidates existing data on the global prevalence, incidence, and psychological comorbidities associated with psoriatic arthritis.
A new overview of systematic reviews consolidates existing data on the global prevalence, incidence, and psychological comorbidities associated with psoriatic arthritis.
The dermatology experts effort aims to reduce diagnostic delays and improve comparability in global research on generalized pustular psoriasis, which has previously lacked universally accepted clinical parameters.
The dermatology experts effort aims to reduce diagnostic delays and improve comparability in global research on generalized pustular psoriasis, which has previously lacked universally accepted clinical parameters.
In this expert update, Dr Paul Nghiem shares advancements in local and regional management of Merkel cell carcinoma, emphasizing the importance of individualized treatment plans.
In this expert update, Dr Paul Nghiem shares advancements in local and regional management of Merkel cell carcinoma, emphasizing the importance of individualized treatment plans.
This whitepaper provides a comprehensive overview of advanced cutaneous squamous cell carcinoma (aCSCC) and advanced basal cell carcinoma (aBCC), highlighting key aspects of disease pathology, diagnosis, and treatment strategies.
This whitepaper provides a comprehensive overview of advanced cutaneous squamous cell carcinoma (aCSCC) and advanced basal cell carcinoma (aBCC), highlighting key aspects of disease pathology, diagnosis, and treatment strategies.
Explore how patients and providers can align on defining atopic dermatitis (AD) flares to improve communication, treatment decisions, and shared decision-making. Take this interactive quiz to test your knowledge and learn how patient-centered...
Explore how patients and providers can align on defining atopic dermatitis (AD) flares to improve communication, treatment decisions, and shared decision-making. Take this interactive quiz to test your knowledge and learn how patient-centered...
Psoriasis has traditionally been viewed as a chronic inflammatory disease confined to the skin. However, growing evidence from dermatologic, rheumatologic, and cardiologic research supports its classification as a systemic disease.
Psoriasis has traditionally been viewed as a chronic inflammatory disease confined to the skin. However, growing evidence from dermatologic, rheumatologic, and cardiologic research supports its classification as a systemic disease.
How well do you understand the patient perspective on atopic dermatitis flares? Take this quiz to explore key patient-described flare indicators, emotional and social impacts, and insights from NEA research.
How well do you understand the patient perspective on atopic dermatitis flares? Take this quiz to explore key patient-described flare indicators, emotional and social impacts, and insights from NEA research.
Dr Patrick Burnett discusses the significance of roflumilast cream, a non-steroidal treatment, its rapid itch relief within 24 hours, and its role in long-term disease management.
Dr Patrick Burnett discusses the significance of roflumilast cream, a non-steroidal treatment, its rapid itch relief within 24 hours, and its role in long-term disease management.
Lead the way in advanced non-melanoma skin cancer (aNMSC) care. Join the free May 1 summit for expert guidance on immuno-oncology (IO) therapy, practice management, and more. Gain the tools to elevate your approach—reserve your spot today.
Stay informed on Alopecia Areata (AA) with a variety of engaging resources designed to fit your learning preferences. Whether you prefer to watch, listen, or read, we’ve got you covered. Check out the content today!
In partnership with National Alopecia Areata Foundation
Watch 5 insightful videos featuring Dr Brad Glick, Dr Saakshi Khattri, and Dr Abel Jarell that explore challenges with psoriasis diagnosis and treatment in patients with obesity. View today!
This real-world patient journey presentation, featuring Dr Todd Schlesinger, discusses BCC, the importance of multidisciplinary care, potential treatment options, and clinical data.
A 27-year-old woman with a past medical history of hypothyroidism presented to the clinic for concerns of a lesion on her right knee at the site of a previous scar.
A 27-year-old woman with a past medical history of hypothyroidism presented to the clinic for concerns of a lesion on her right knee at the site of a previous scar.
A healthy 55-year-old woman with no prior skin cancer history and no personal or family history of genodermatoses presented with a painless lesion on the right central cheek.
A healthy 55-year-old woman with no prior skin cancer history and no personal or family history of genodermatoses presented with a painless lesion on the right central cheek.
Dr Patrick Burnett discusses the significance of roflumilast cream, a non-steroidal treatment, its rapid itch relief within 24 hours, and its role in long-term disease management.
Dr Patrick Burnett discusses the significance of roflumilast cream, a non-steroidal treatment, its rapid itch relief within 24 hours, and its role in long-term disease management.
Gain practical insights on improving diagnostic accuracy, minimizing unnecessary interventions, and refining patient-centered strategies for melanoma screening in daily practice.
Gain practical insights on improving diagnostic accuracy, minimizing unnecessary interventions, and refining patient-centered strategies for melanoma screening in daily practice.
National Eczema Association survey examines the frequency of acute care needs among patients with atopic dermatitis and the wait times they experience when seeking care from their primary atopic dermatitis health care providers.
National Eczema Association survey examines the frequency of acute care needs among patients with atopic dermatitis and the wait times they experience when seeking care from their primary atopic dermatitis health care providers.
The National Psoriasis Foundation’s first-ever health indicator report takes a deep dive into the health burden of psoriatic disease, treatment gaps, and future directions in care.
The National Psoriasis Foundation’s first-ever health indicator report takes a deep dive into the health burden of psoriatic disease, treatment gaps, and future directions in care.
Dispelling common misconceptions about the disease and advancing the development of more tolerable topical and oral therapies can offer hope for improved patient outcomes.
Dispelling common misconceptions about the disease and advancing the development of more tolerable topical and oral therapies can offer hope for improved patient outcomes.
Climbing the mountain to get to dermatology residency is bone breaking enough, but what about the next apex, even more specialized training such as a Dermatopathology Fellowship?
Climbing the mountain to get to dermatology residency is bone breaking enough, but what about the next apex, even more specialized training such as a Dermatopathology Fellowship?
In our next segment of the ElderDerm Podcast, listen to co-hosts Dr Adam Friedman and Jaya Manjunath discuss what shared decision-making is, and why it is important in dermatology.
In our next segment of the ElderDerm Podcast, listen to co-hosts Dr Adam Friedman and Jaya Manjunath discuss what shared decision-making is, and why it is important in dermatology.
Featuring co-hosts Dr Adam Friedman and Jaya Manjunath
Featuring co-hosts Dr Adam Friedman a...
In this episode of the ElderDerm Podcast, co-hosts Dr Adam Friedman and Jaya Manjunath discuss the Aging and Geriatric Evaluation in Dermatology (AGED) workgroup.
In this episode of the ElderDerm Podcast, co-hosts Dr Adam Friedman and Jaya Manjunath discuss the Aging and Geriatric Evaluation in Dermatology (AGED) workgroup.
Listen to the first ElderDerm Podcast, where co-hosts Dr Adam Friedman and Jaya Manjunath discuss what is geriatric dermatology, and why there is a need for this area in training.
Listen to the first ElderDerm Podcast, where co-hosts Dr Adam Friedman and Jaya Manjunath discuss what is geriatric dermatology, and why there is a need for this area in training.
A new overview of systematic reviews consolidates existing data on the global prevalence, incidence, and psychological comorbidities associated with psoriatic arthritis.
A new overview of systematic reviews consolidates existing data on the global prevalence, incidence, and psychological comorbidities associated with psoriatic arthritis.
The dermatology experts effort aims to reduce diagnostic delays and improve comparability in global research on generalized pustular psoriasis, which has previously lacked universally accepted clinical parameters.
The dermatology experts effort aims to reduce diagnostic delays and improve comparability in global research on generalized pustular psoriasis, which has previously lacked universally accepted clinical parameters.
Psoriasis has traditionally been viewed as a chronic inflammatory disease confined to the skin. However, growing evidence from dermatologic, rheumatologic, and cardiologic research supports its classification as a systemic disease.
Psoriasis has traditionally been viewed as a chronic inflammatory disease confined to the skin. However, growing evidence from dermatologic, rheumatologic, and cardiologic research supports its classification as a systemic disease.
A retrospective observational study suggests that the risk of developing psoriatic arthritis in patients with plaque psoriasis may vary depending on the class of biologic therapy used.
A retrospective observational study suggests that the risk of developing psoriatic arthritis in patients with plaque psoriasis may vary depending on the class of biologic therapy used.
Explore how patients and providers can align on defining atopic dermatitis (AD) flares to improve communication, treatment decisions, and shared decision-making. Take this interactive quiz to test your knowledge and learn how patient-centered...
Explore how patients and providers can align on defining atopic dermatitis (AD) flares to improve communication, treatment decisions, and shared decision-making. Take this interactive quiz to test your knowledge and learn how patient-centered...
How well do you understand the patient perspective on atopic dermatitis flares? Take this quiz to explore key patient-described flare indicators, emotional and social impacts, and insights from NEA research.
How well do you understand the patient perspective on atopic dermatitis flares? Take this quiz to explore key patient-described flare indicators, emotional and social impacts, and insights from NEA research.
Test your knowledge of how patients with atopic dermatitis (AD) define and experience flares. This quiz highlights key indicators, patient-described attributes, and insights from the NEA’s research into AD flare triggers and symptoms.
Test your knowledge of how patients with atopic dermatitis (AD) define and experience flares. This quiz highlights key indicators, patient-described attributes, and insights from the NEA’s research into AD flare triggers and symptoms.
1. How do JAK inhibitors differ from traditional immunosuppressant treatments for atopic dermatitis?a) They work extracellularly, directly blocking cytokines.b) They target inflammation at the intracellular level and are more selective.c)...
1. How do JAK inhibitors differ from traditional immunosuppressant treatments for atopic dermatitis?a) They work extracellularly, directly blocking cytokines.b) They target inflammation at the intracellular level and are more selective.c)...
In this interview, Dr Ablon explored cutting-edge techniques, personalized approaches, and practical insights in appearance procedures by addressing complications, patient satisfaction, and guidance for dermatologists.
In this interview, Dr Ablon explored cutting-edge techniques, personalized approaches, and practical insights in appearance procedures by addressing complications, patient satisfaction, and guidance for dermatologists.
Dr Jonathan Silverberg discussed how he hoped physicians gained a better understanding of the latest research and approaches when treating atopic dermatitis during the Revolutionizing Atopic Dermatitis virtual session.
Dr Jonathan Silverberg discussed how he hoped physicians gained a better understanding of the latest research and approaches when treating atopic dermatitis during the Revolutionizing Atopic Dermatitis virtual session.
In this interview, Dr Etzkorn and Dr Golda discussed the findings of their multi-center prospective cohort study on patients undergoing 2-stage interpolated flap repair for nasal defects.
In this interview, Dr Etzkorn and Dr Golda discussed the findings of their multi-center prospective cohort study on patients undergoing 2-stage interpolated flap repair for nasal defects.
In this interview with The Dermatologist, Dr Steven Feldman discusses his session, “Better Care for Psoriasis Patients,” presented at Fall Dermatology Week 2023.
In this interview with The Dermatologist, Dr Steven Feldman discusses his session, “Better Care for Psoriasis Patients,” presented at Fall Dermatology Week 2023.
In this feature interview with The Dermatologist, Dr Derek Chu discusses systemic treatments for atopic dermatitis and also how physicians can consider the benefits and harms of prescription topical treatments.
In this feature interview with The Dermatologist, Dr Derek Chu discusses systemic treatments for atopic dermatitis and also how physicians can consider the benefits and harms of prescription topical treatments.
In this engaging interview, Dr Hussain discusses international variations in Mohs practice and shares insights from his session, “International Perspectives on Mohs & Facial Reconstruction,” presented at the 2023 American College of Mohs...
In this engaging interview, Dr Hussain discusses international variations in Mohs practice and shares insights from his session, “International Perspectives on Mohs & Facial Reconstruction,” presented at the 2023 American College of Mohs...
Read about the latest insights in skin cancer care with a new whitepaper on advanced basal cell carcinoma and advanced cutaneous squamous cell carcinoma. View the complimentary resource today!
In this interview, Dr Loren Krueger discusses her latest session: “Central Centrifugal Cicatricial Alopecia: Advances in Diagnosis and Treatment,” at the 2023 AAD Annual Meeting.
In this interview, Dr Loren Krueger discusses her latest session: “Central Centrifugal Cicatricial Alopecia: Advances in Diagnosis and Treatment,” at the 2023 AAD Annual Meeting.
Eva Kerby, MD, who presented “Understanding and Minimizing Keloids” at Dermatology Week 2023, emphasized the importance of understanding the pathophysiology and epidemiology of keloids to effectively treat them.
Eva Kerby, MD, who presented “Understanding and Minimizing Keloids” at Dermatology Week 2023, emphasized the importance of understanding the pathophysiology and epidemiology of keloids to effectively treat them.
In this interview, Dr Ramone Williams discusses her session, “Pro and Con: Contentious Concepts,” at the 2023 ACMS Annual Meeting. She covered the topic, “Mohs vs Topical Therapy for Squamous Cell Carcinoma in Situ: Pro Mohs.”
In this interview, Dr Ramone Williams discusses her session, “Pro and Con: Contentious Concepts,” at the 2023 ACMS Annual Meeting. She covered the topic, “Mohs vs Topical Therapy for Squamous Cell Carcinoma in Situ: Pro Mohs.”
Researchers aimed to investigate the potential association between androgenetic alopecia and metabolic syndrome by examining the thickness of subcutaneous adipose tissue in the scalp.
Researchers aimed to investigate the potential association between androgenetic alopecia and metabolic syndrome by examining the thickness of subcutaneous adipose tissue in the scalp.
It is important to acknowledge and address contributing factors to prevent chronic symptoms of Lyme borreliosis disproportionately affecting patients with skin of color.
It is important to acknowledge and address contributing factors to prevent chronic symptoms of Lyme borreliosis disproportionately affecting patients with skin of color.
Explore how patients and providers can align on defining atopic dermatitis (AD) flares to improve communication, treatment decisions, and shared decision-making. Take this interactive quiz to test your knowledge and learn how patient-centered...
Explore how patients and providers can align on defining atopic dermatitis (AD) flares to improve communication, treatment decisions, and shared decision-making. Take this interactive quiz to test your knowledge and learn how patient-centered...
How well do you understand the patient perspective on atopic dermatitis flares? Take this quiz to explore key patient-described flare indicators, emotional and social impacts, and insights from NEA research.
How well do you understand the patient perspective on atopic dermatitis flares? Take this quiz to explore key patient-described flare indicators, emotional and social impacts, and insights from NEA research.
Test your knowledge of how patients with atopic dermatitis (AD) define and experience flares. This quiz highlights key indicators, patient-described attributes, and insights from the NEA’s research into AD flare triggers and symptoms.
Test your knowledge of how patients with atopic dermatitis (AD) define and experience flares. This quiz highlights key indicators, patient-described attributes, and insights from the NEA’s research into AD flare triggers and symptoms.
1. How do JAK inhibitors differ from traditional immunosuppressant treatments for atopic dermatitis?a) They work extracellularly, directly blocking cytokines.b) They target inflammation at the intracellular level and are more selective.c)...
1. How do JAK inhibitors differ from traditional immunosuppressant treatments for atopic dermatitis?a) They work extracellularly, directly blocking cytokines.b) They target inflammation at the intracellular level and are more selective.c)...